Orchazid 0.025% eye drops 10 ml

Tradename

Orkhazid

Orchazid

Compound:

Each 1 ml drops contains:

Ketotifen 0.25 mg

Benzalkonium chloride 0.1 mg

Properties

Ketotifen belongs to the group of cycloheptathiophenones and has a pronounced antihistamine effect. Does not apply to bronchodilatory anti-asthma drugs. The mechanism of action is associated with inhibition of the release of histamine and other mediators from mast cells, blocking histamine H1 receptors and inhibition of the phosphodiesterase enzyme, resulting in an increase in the level of cAMP (cyclic adenosine monophosphate) in mast cells.

Indications

Prevention and treatment of acute, subacute and chronic allergic conjunctivitis and keratoconjunctivitis, seasonal (spring) conjunctivitis, eye manifestations of hay fever. In the form of tablets, it is used to prevent the development of bronchospasm, asthmatic attacks and acute allergic reactions, to reduce the dose and / or cancel hormonal drugs (glucocorticosteroids) and bronchodilators in their combined use.

Dosage and administration

The drug in the form of drops for adults and children over the age of 12 is prescribed 1 drop in the conjunctival sac of each eye 2 times a day. Prophylactic administration in subacute and chronic processes should be started 3 weeks before contact with the allergen. Treatment is continued during the entire period of exposure to allergens. The duration of the use of eye drops depends on the type and severity of the disease. The bottle should be carefully closed after each use.

Contraindications

Hypersensitivity to ketotifen and other components of the drug, the period of pregnancy and lactation; children under the age of 3 years.

Precautionary measures:

In acute inflammation and during an exacerbation of a chronic process, it is possible to use the drug in combination with corticosteroids. The patient should be warned about the need for regular use of the drug. Treatment begins before contact with the allergen and continues for the entire period of the allergen. The drug should not be used simultaneously with antidiabetic agents. When using eye drops, soft contact lenses should not be used due to the presence of benzalkonium chloride in the composition. Rigid contact lenses should be removed from the eyes immediately before instillation of drops and inserted no earlier than 15 minutes after using the drug.

Side effects

Burning sensation and tingling in the eyes, blurred vision immediately after instillation. Irritation of the mucous membrane of the eye, skin rash around the eyes; hypersensitivity.

Storage method:

Store at a temperature not exceeding 30 degrees.